미 바이오기업 모더나 "코로나19 백신 임상시험서 항체 형성"<br /><br />U.S. biotech company Moderna says there have been some promising early results from its first human tests for a potential vaccine for COVID-19.<br />It said the vaccine produced virus-fighting antibodies in all 45 participants that were similar or greater than those in patients who had recovered from the virus.<br />The vaccine also produced neutralizing antibodies in at least eight participants, which is considered important in acquiring protection.<br />Approved by the FDA last month, Moderna will proceed with the second phase of testing involving 600 people.<br />
